July 15, 2024 – In an unprecedented surge, Trump Media & Technology Group (NASDAQ: DJT) saw its stock price skyrocket in pre-market trading today, following news of an assassination attempt on former President Donald Trump. The attempted attack, which occurred late last night, has not only brought a wave of sympathy but also renewed investor interest in Trump-associated enterprises.

The former President, who is also a key figure in the company, survived the attempt unharmed. Sources close to the situation indicate that the incident has galvanized his support base and investors alike, pushing DJT shares up by over 25% in the early hours of trading.

Bullish Sentiment on Small Caps

The heightened market activity surrounding DJT has also cast a bullish light on several small-cap stocks. Among the noteworthy mentions are:

• Catheter Precision Inc. (NYSE American: VTAK): Specializing in innovative medical devices, Catheter Precision is gaining traction as it reports positive clinical data and expands its intellectual property portfolio. The market is bullish on VTAK, anticipating strong revenue growth driven by its advanced healthcare solutions expansion strategy following a new stock structure (1 for 10 stock split) which begins today.  
• Peraso Inc. (NASDAQ: PRSO): Known for its cutting-edge mmWave technology, Peraso Inc. is attracting attention due to its recent technological advancements and ISO 9001:2015 certification. Investors are optimistic about the company’s future, predicting significant growth in the semiconductor sector. Ladenburg Thalmann initiates coverage.  
• Dyadic International Inc. (NASDAQ: DYAI): With a focus on synthetic biology and biopharmaceutical applications, Dyadic International has been a consistent performer. The company’s recent strides in gene expression and enzyme production have bolstered investor confidence, making DYAI a small-cap to watch. Zacks SmallCap valued Dyadic at $9 a share in a July 1 report, read entire report now and See HC Wainwright & Co Buy Recommendation. 
• Intelligent Bio Solutions Inc. (NASDAQ: INBS): This biotech firm, known for its groundbreaking work in diagnostics and bioinformatics, has seen a renewed increased in investor interest. INBS’s innovative solutions in personalized medicine are driving its stock upwards as the company continues to make headway in the biotech industry.

Market Dynamics

The assassination attempt on Donald Trump has not only impacted Trump Media but has also created a ripple effect across the stock market, particularly benefiting these small-cap stocks. Analysts suggest that the heightened media coverage and public attention could sustain this bullish trend, at least in the short term.

Investors are advised to keep a close watch on these developments as the market reacts to the unfolding events. The interplay between political events and market dynamics continues to present both opportunities and risks, underscoring the importance of informed investment decision.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com